PEDEvidence@pedevidence

SOURCE-LINKED STUDY SUMMARY

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?

Diabetes care ·

Review

Abstract summarizedQuality not appraised
What was studied
Abstract-based narrative review of incretin weight-loss drugs and whether resistance exercise could help preserve lean mass; it did not test a new intervention or comparator.
Who / model studied
This was a narrative review rather than a newly enrolled cohort; the abstract reports no participant sample size.
Studied dose & schedule
Dose and schedule have not yet been extracted for this summary.
What the study found
The review reports substantial weight loss with incretin drugs alongside lean-mass loss, and cites resistance-training studies lasting more than 10 weeks that increased lean mass and strength.
Limitations & context
No direct trial of resistance exercise during incretin therapy is presented; the exercise recommendation is the authors’ proposal, so preservation during treatment remains untested here.

Read summary source ↗ · Prepared 9/23/2026 · AI-assisted, source-based summary

Review record & corrections

Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.

No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.

Inspect the source · Correction policy

Save, annotate or compare this study in the library →

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.2337/dci23-0100

Explore related compounds

Evidence and review standards

← All study summaries